Showing results (61-70 of 1,561) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|August 18, 2022
CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p/ALG3 axisZhen Shang, Xi Ming, Jiaying Wu, et al.Expert Review of Hematology|December 13, 2021
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patientsMassimo Breccia, Emilia Scalzulli, Sara Pepe, et al.Expert Review of Hematology|November 5, 2021
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advancesMassimiliano Camilli, Giulia La Vecchia, Rosa Lillo, et al.Expert Review of Hematology|October 31, 2022
Copper deficiency, a rare but correctable cause of pancytopenia: a review of literatureNayha Tahir, Aqsa Ashraf, Syed Hamza Bin Waqar, et al.Expert Review of Hematology|October 3, 2022
Emicizumab: a novel drug in hemophilia A prophylaxis - a narrative reviewŁukasz Mazurkiewicz, Krystian Czernikiewicz, Joanna Rupa-Matysek, et al.Expert Review of Hematology|April 19, 2011
Dose escalation of imatinib in chronic-phase chronic myeloid leukemia patients: is it still reasonable?Jakob Rudzki, Dominik WolfExpert Review of Hematology|June 15, 2011
Dasatinib for the treatment of chronic myeloid leukemiaAmber Fullmer, Hagop Kantarjian, Jorge Cortes, et al.Expert Review of Hematology|June 15, 2011
Managing multiple myeloma in the elderly: are we making progress?Hang Quach, H Miles Prince, Andrew SpencerExpert Review of Hematology|June 15, 2011
Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemiaCharalampos Pontikoglou, Christina Kalpadakis, Helen A PapadakiExpert Review of Hematology|September 8, 2015
Idelalisib for relapsed/refractory indolent B-cell non-Hodgkin's lymphoma: an overview of pharmacokinetics and clinical trial outcomesAndrew DaviesPageof 157